Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.

Because of the potential of novobiocin-rifampin for oral therapy of methicillin-resistant Staphylococcus aureus infection, we evaluated the pharmacokinetics of novobiocin and rifampin, alone and in combination, in a randomized, crossover, multiple-dose evaluation (500 mg of novobiocin and 300 mg of...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Drusano, G L, Townsend, R J, Walsh, T J, Forrest, A, Antal, E J, Standiford, H C
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1986
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176432/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3752982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.1.42
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!